ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,416,753,000 | +280.6% | 36,763 | +143.9% | 0.01% | +400.0% |
| Q3 2021 | $897,776,000 | +119.8% | 15,076 | +151.8% | 0.00% | 0.0% |
| Q2 2021 | $408,382,000 | -74.3% | 5,988 | -73.9% | 0.00% | -50.0% |
| Q1 2021 | $1,591,113,000 | +137.8% | 22,930 | +163.3% | 0.00% | +100.0% |
| Q4 2020 | $669,036,000 | -35.0% | 8,708 | -36.7% | 0.00% | 0.0% |
| Q3 2020 | $1,029,410,000 | +60.7% | 13,764 | +35.3% | 0.00% | 0.0% |
| Q2 2020 | $640,453,000 | -49.1% | 10,174 | -66.1% | 0.00% | -66.7% |
| Q1 2020 | $1,259,328,000 | +103.3% | 29,984 | +119.9% | 0.00% | +200.0% |
| Q4 2019 | $619,302,000 | -14.6% | 13,635 | -13.9% | 0.00% | 0.0% |
| Q3 2019 | $724,814,000 | +86.8% | 15,836 | +139.3% | 0.00% | 0.0% |
| Q2 2019 | $387,955,000 | -24.6% | 6,617 | -42.3% | 0.00% | 0.0% |
| Q1 2019 | $514,335,000 | +1067.6% | 11,473 | +914.4% | 0.00% | – |
| Q4 2018 | $44,052,000 | -66.1% | 1,131 | -59.9% | 0.00% | – |
| Q3 2018 | $129,868,000 | +15.1% | 2,822 | +9.1% | 0.00% | – |
| Q2 2018 | $112,793,000 | -66.9% | 2,587 | -70.1% | 0.00% | -100.0% |
| Q1 2018 | $341,201,000 | -87.9% | 8,638 | -89.6% | 0.00% | -80.0% |
| Q4 2017 | $2,817,132,000 | +1986.6% | 82,930 | +1518.1% | 0.01% | – |
| Q3 2017 | $135,013,000 | +53.9% | 5,125 | +9.2% | 0.00% | – |
| Q2 2017 | $87,754,000 | – | 4,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |